NFE2L2 and neoplasm: Further, this group proposes a novel NRF2 genetic target (macrophage colony-stimulating factor; M-CSF), a known inducer of macrophage polarisation, as a key contributor to the iASPP-NRF2 axis and thus to the chemotherapeutic resistance within tumours [184].